DJIA 18,135.72 38.82 0.21%
NASDAQ 4,982.81 15.67 0.32%
S&P 500 2,101.04 2.51 0.12%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

57.98 0.10 (0.17%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $57.98 0.17%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $58.09
Previous Close $57.88
Daily Range $57.80 - $58.28
52-Week Range $52.49 - $63.62
Market Cap $164.6B
P/E Ratio 14.22
Dividend (Yield) $1.80 (3.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 11,528,464
Average Daily Volume 9,970,581
Current FY EPS $3.43




Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary Rss Feed

Billionaire George Soros Just Dumped These 3 Dividend Stocks

Controversial hedge fund tycoon George Soros just sold three top dividend stocks. Should you follow his lead?

FDA Surprises Everyone With Super-Fast Opdivo Lung Cancer Approval

Dow Jones (DJIA) Today: Merck (MRK) Higher

Geron's Q4 Loss Narrows Y/Y, Announces Restructuring Plan - Analyst Blog

Bristol-Myers Squibb’s $1.6 Billion On New Drug Deals Is Well Spent

Merck’s Partnership With NGM Is A Bold Move

Fast Money Picks For March 2

This Billionaire CEO Just Made Another Biotech Acquisition -- and Hardly Anyone Noticed

Intrexon, led by biotech billionaire R.J. Kirk, acquired a little known Belgian biotech. Is it a big deal for investors?

Which Cancer Immunotherapy Will Be the Most Successful?

Motley Fool experts discuss whether Bristol-Myers Squibb's Opdivo or Merck & Co.'s Keytruda will be the bigger commercial success.

Bayer Q4 Net Income Down Y/Y, Provides 2015 Outlook - Analyst Blog

See More MRK News...

MRK's Top Competitors

MRK $57.98 (0.17%)
Current stock: MRK
JNJ $102.52 (0.86%)
Current stock: JNJ
NVS $98.95 (-0.09%)
Current stock: NVS
RHHBY $32.80 (-1.07%)
Current stock: RHHBY